Development of a Novel Multiplex Bead-based Assay for Measuring Autoantibodies on Flow Cytometric Platform

References

• Beutner EH, Binder WL, Fang YV, Plunkett RW, Rubin RL. 1998. Antinuclear antibodies (ANA) and complement fixing ANA in systemic connective tissue diseases. Immunol Invest. 27:97–104.
   PubMed Web of Science ®Google Scholar
• Biagini RE, Murphy DM, Sammons DL, Smith JP, Striley CA, MacKenzie BA. 2002. Development of multiplexed fluorescence microbead covalent assays (FMCAs) for pesticide biomonitoring. Bull Environ Contam Toxicol. 68:470.
   PubMed Web of Science ®Google Scholar
• Callado MR, Barroso MN, Alves VM, Abreu MA, Muniz LM, Lima JR. 2014. Antinuclear antibodies: two-step detection strategy. Immunol Invest. 43(1):86–95.
   PubMed Web of Science ®Google Scholar
• Carson RT, Vignali DA. 1999. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods. 227(1–2):41–52.
   PubMed Web of Science ®Google Scholar
• Cervera R. 2001. The epidemiology and significance of autoimmune diseases in health care. Scand J Clin Lab Invest. 61(235):27–30.
   PubMed Web of Science ®Google Scholar
• Chauhan R, Jain D, Dorwal P, Roy G, Raina SP, Nandi V. 2019. The incidence of immunofluorescence patterns and specific autoantibodies observed in autoimmune patients in a tertiary care centre. Eur Ann Allergy Clin Immunol. 51:165–73.
   PubMed Web of Science ®Google Scholar
• Chugh PK, Kalra BS. 2012. Belimumab: targeted therapy for lupus. Int J Rheum Dis. 16(1):4–13.
   PubMed Web of Science ®Google Scholar
• Clotet B, Guardia J, Pigrau C, Lience E, Murcia C, Pujol R, Bacardi R. 1984. Incidence and clinicai significance of anti-ENA antibodies in systemic lupus erythematosus: estimationby counterimmunoelectrophoresis. Scand J Rheumatol. 13:15–20.
   PubMed Web of Science ®Google Scholar
• Conrad K, Roggenbuck D, Ittenson A, Reinhold D, Buettner T, Laass MW. 2012a. A new dot immunoassay for simultaneous detection of celiac specific antibodies and IgA-deficiency. Clin Chem Lab Med. 50(2):337–43.
   PubMed Web of Science ®Google Scholar
• Conrad K, Roggenbuck D, Reinhold D, Dörner T. 2010. Profiling of rheumatoid arthritis associated autoantibodies. Autoimmun Rev. 9(6):431–35.
   PubMed Web of Science ®Google Scholar
• Conrad K, Roggenbuck D, Reinhold D, Sack U. 2012b. Autoantibody diagnostics in clinical practice. Autoimmun Rev. 11(3):207–11.
   PubMed Web of Science ®Google Scholar
• Conrad K, Schneider H, Ziemssen T, Talaska T, Reinhold D, Humbel RL, Roggenbuck D. 2007. A new line immunoassay for the multiparametric detection of antiganglioside autoantibodies in patients with autoimmune peripheral neuropathies. Ann N Y Acad Sci. 1109(1):256–64.
   PubMedGoogle Scholar
• De Beeck KO, Vermeersch P, Verschueren P, Westhovens R, Mariën G, Blockmans D, Bossuyt X. 2011. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev. 10(12):801–08.
   PubMed Web of Science ®Google Scholar
• De Beéck KO, Vermeersch P, Verschueren P, Westhovens R, Mariën G, Blockmans D, Bossuyt X. 2012. Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun Rev. 12(2):137–43.
   PubMed Web of Science ®Google Scholar
• De Voer RM, van der Klis FR, Engels CW, Rijkers GT, Sanders EA, Berbers GA. 2008. Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides. Clin Vaccine Immunol. 15(8):1188–93.
   PubMedGoogle Scholar
• Desplat-Jego SO, Bardin N, Larida B, Sanmarco M. 2007. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods. Ann N Y Acad Sci. 1109(1):245–55.
   PubMedGoogle Scholar
• Egerer K, Roggenbuck D, Hiemann R, Weyer MG, Büttner T, Radau B, Krause R, Lehmann B, Feist E, Burmester GR. 2010. Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Res Ther. 12(2):R40.
   PubMed Web of Science ®Google Scholar
• El-Chennawi FA, Mosaad YM, Habib HM, El-Degheidi T. 2009. Comparative study of antinuclear antibody detection by indirect immunofluorescence and enzyme immunoassay in lupus patients. Immunol Invest. 38(8):839–50.
   PubMed Web of Science ®Google Scholar
• Fenger M, Wiik A, Høier-Madsen M, Lykkegaard JJ, Rozenfeld T, Hansen MS, Samsoe BD, Jacobsen S. 2004. Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. Clin Chem. 50(11):2141–47.
   PubMed Web of Science ®Google Scholar
• Fouda GG, Leke RF, Long C, Druilhe P, Zhou A, Taylor DW, Johnson AH. 2006. Multiplex assay for simultaneous measurement of antibodies to multiple plasmodium falciparum antigens. Clin Vaccine Immunol. 13(12):1307–13.
   PubMedGoogle Scholar
• Friou GJ. 1958. Clinical application of a test for lupus globulin-nucleohistone interaction using fluorescent antibody. Yale J Biol Med. 31:40.
   PubMedGoogle Scholar
• Fritzler MJ. 2008. Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev. 7(8):616–20.
   PubMed Web of Science ®Google Scholar
• Fritzler MJ. 2011. The antinuclear antibody test: last or lasting gasp? Arthritis & Rheumatism. 63(1):19–22.
   PubMedGoogle Scholar
• Fulton RJ, McDade RL, Smith PL, Kienker LJ, Kettman JR Jr. 1997. Advanced multiplexed analysis with the FlowMetrixTM system. Clin Chem. 43(9):1749–56.
   PubMed Web of Science ®Google Scholar
• Ghillani P, Rouquette AM, Desgruelles C, Hauguel N, Le Pendeven C, Piette JC, Musset L. 2007. Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases. Ann N Y Acad Sci. 1109(1):407–13.
   PubMedGoogle Scholar
• Gohill JI, Cary PD, Couppez MA, Fritzler MJ. 1985. Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone. J Immunol. 135:3116–21.
   PubMed Web of Science ®Google Scholar
• Goldblatt F, O’Neill SG. 2013. Clinical aspects of autoimmune rheumatic diseases. The Lancet. 382(9894):797–808.
   PubMed Web of Science ®Google Scholar
• González C, García-Berrocal B, Pérez M, Navajo JA, Herraez O, González-Buitrago JM. 2005. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients. Clinica Chimica Acta. 359(1–2):109–14.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Buitrago JM. 2006. Multiplexed testing in the autoimmunity laboratory. Clin Chem Lab Med. 44(10):1169–74.
   PubMed Web of Science ®Google Scholar
• Gurevitz S, Snyder J, Wessel E, Frey J, Williamson B. 2013. Williamson. Systemic lupus erythematosus: A review of the disease and treatment options. The Consultant Pharmacist. 28(2):110–21.
   PubMedGoogle Scholar
• Habash-Bseiso DE, Yale SH, Glurich I, Goldberg JW. 2005. Serologic testing in connective tissue diseases. Clin Med Res. 3(3):190–93.
   PubMedGoogle Scholar
• Hanly JG, Su L, Farewell V, Fritzler MJ. 2010a. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. J Immunol Methods. 358(1–2):75–80.
   PubMed Web of Science ®Google Scholar
• Hanly JG, Thompson K, McCurdy G, Fougere L, Theriault C, Wilton K. 2010b. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus. J Immunol Methods. 352(1–2):147–52.
   PubMed Web of Science ®Google Scholar
• Hayashi N, Kawamoto T, Mukai M, Morinobu A, Koshiba M, Kondo S, Maekawa S, Kumagai S. 2001. Detection of antinuclear antibodies by use of an enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: comparison with immunofluorescence assay in 307 patients. Clin Chem. 47(9):1649–59.
   PubMed Web of Science ®Google Scholar
• Ho KT, Reveille JD. 2003. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther. 5:80.
   PubMed Web of Science ®Google Scholar
• Jacobson RH. 1998. Validation of serological assays for diagnosis of infectious diseases. Revue Scientifique Et Technique De l’OIE. 17:469–526.
   PubMed Web of Science ®Google Scholar
• John KJ, Sadiq M, George T, Gunasekaran K, Francis N, Rajadurai E, Sudarsanam TD. 2020. Clinical and immunological profile of mixed connective tissue disease and a comparison of four diagnostic criteria. Int J Rheumatol. Jan. 29:1–67.
   Google Scholar
• Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. 2000. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med Pathology. 124:71–81.
   PubMed Web of Science ®Google Scholar
• Kellar KL. 2002. Multiplexed microsphere-based flow cytometric assays. Exp Hematol. 30(11):1227–37.
   PubMed Web of Science ®Google Scholar
• Kim Y, Park Y, Lee EY, Kim HS. 2012. Comparison of automated multiplexed bead-based ANA screening assay with ELISA for detecting five common anti-extractable nuclear antigens and anti-dsDNA in systemic rheumatic diseases. Clinica Chimica Acta. 413(1–2):308–11.
   PubMed Web of Science ®Google Scholar
• Kumar V, Krasny S, Beutner EH. 1985. Specificity of the Crithidia luciliae method for detecting anti-DNA antibodies. Effect of absorption for lipoproteins. Immunol Invest. 14(3):199–210.
   PubMed Web of Science ®Google Scholar
• Lal G, Balmer P, Joseph H, Dawson M, Borrow R. 2004. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to neisseria meningitidis serogroups A, C, Y, and W-135. Clin. Diagn. Lab. Immunol. 11:272–79.
   PubMedGoogle Scholar
• Meroni PL, Schur PH. 2010. ANA screening: an old test with new recommendations. Ann Rheum Dis. 69(8):1420–22.
   PubMed Web of Science ®Google Scholar
• Moder K. 1996. Use and interpretation of rheumatologic tests: A guide for clinicians. Mayo Clin Proc. 71:391–96.
   PubMed Web of Science ®Google Scholar
• Nifli AP, Notas G, Mamoulaki M, Niniraki M, Ampartzaki V, Theodoropoulos PA, Kopnitsky MJ, Castanas E. 2006. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. J Immunol Methods. 311(1–2):189–97.
   PubMed Web of Science ®Google Scholar
• Roggenbuck D, Egerer K, Feist E, Burmester GR, Dörner T. 2012a. Antiphospholipid antibody profiling: association with the clinical phenotype of antiphospholipid syndrome? Comment on the article by Otomo et al. Arthritis & Rheumatism. 64:2807–08.
   PubMedGoogle Scholar
• Roggenbuck D, Egerer K, Von Landenberg P, Hiemann R, Feist E, Burmester GR, Dörner T. 2012b. Antiphospholipid antibody profiling-Time for a new technical approach? Autoimmun Rev. 11(11):821–26.
   PubMed Web of Science ®Google Scholar
• Sack U, Conrad K, Csernok E, Frank I, Hiepe F, Krieger T, Kromminga A, Von Landenberg P, Messer G, Witte T, et al. 2009. Autoantibody detection using indirect immunofluorescence on HEp-2 cells. Ann N Y Acad Sci. 1173(1):166–73.
   PubMedGoogle Scholar
• Satoh M, Tanaka S, Chan EK. 2015. The uses and misuses of multiplex autoantibody assays in systemic autoimmune rheumatic diseases. Front Immunol. 6:181.
   PubMed Web of Science ®Google Scholar
• Shovman O, Gilburd B, Barzilai O, Shinar E, Larida B, Zandman‐Goddard G, Binder SR, Shoenfeld Y. 2005. Evaluation of the BioPlex™ 2200 ANA Screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann N Y Acad Sci. 1050:380–88.
   PubMed Web of Science ®Google Scholar
• Stinton LM, Fritzler MJ. 2007. A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders. Autoimmun Rev. 7(1):77–84.
   PubMed Web of Science ®Google Scholar
• Tan EM, Smolen JS, McDougal JS, Butcher BT, Conn D, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, et al. 1999. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities: I. Precision, sensitivity, and specificity. Arthritis & Rheumatism. 42(3):455–64.
   PubMedGoogle Scholar
• Vij R, Strek ME. 2013. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest. 143(3):814–24.
   PubMed Web of Science ®Google Scholar
• Wiik A, Charles P, Meyrowitsch J (2011). Multi-centre collaboration is needed to reach a unified and strictly defined classification of IIF ANA patterns, From Prediction to Prevention of Autoimmune Disease, pp. 634–46.
   Google Scholar
• Zappi E, Sontheimer R. 1993. Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions. Immunol Invest. 22(3):189–203.
   PubMed Web of Science ®Google Scholar